Bioiberica is a biotechnology company specialized in the research, development, production and distribution of biomolecules, innovative ingredients and finished products for the pharmaceutical, nutraceutical and food industries in over 50 countries around the world.
Established in 1975, when the company started to investigate and produce heparin, Bioiberica has gradually increased its specialization in the production of different glycosaminoglycans such as chondroitin sulfate, glucosamine and sodium hyaluronate.
With an extensive experience in the pharmaceutical market, the company has established itself as one of the most prestigious names in the pharmaceutical industry for top quality active ingredients and finished products that are backed by science, and has pioneered advancements in pharmaceuticals and dietary supplements that have led Bioiberica to become a renowned worldwide expert in joint health.
In Spain, Bioiberica is the market leader in prescription drugs for joint health with Condrosan® (chondroitin sulfate 400mg capsules), and the product is also being distributed in several European countries under the brand Cartexan®. Furthermore, Bioiberica commercializes Droglican®, the first and only combination chondroitin/glucosamine authorized as drug in the world.
Today Bioiberica is leading the development in Chondroprotection by sponsoring advanced cartilage research and scientific studies and large-scale joint health clinical trials. Bioiberica’s chondroitin sulfate is the most researched one in the market, with more than 20 clinical trials involving more than 5,000 patients, and up to 43 scientific publications. The company is also investigating in the field of personalized medicine with promising results (genetic testing – Arthrotest®, biomarkers).
And given the fact that 25% of the population is affected by any kind of joint condition, Bioiberica’s firm commitment to science and investigation will fuel the company’s efforts to develop and supply the most innovative and effective ingredients and products for joint health to improve the quality of life for those millions of affected people.
For more information about us please visit www.bioiberica.com